期刊
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
卷 849, 期 1-2, 页码 43-52出版社
ELSEVIER
DOI: 10.1016/j.jchromb.2006.10.069
关键词
cancer; proteomics; plasma proteome; serum proteome; blood proteome; multidimensional separation; biomarkers; protein separation; peptide separation
资金
- NCI NIH HHS [CA77048, CA10815] Funding Source: Medline
- BHP HRSA HHS [SA4100020718] Funding Source: Medline
The plasma proteome has a wide dynamic range of protein concentrations and is dominated by a few highly abundant proteins. Discovery of novel cancer biomarkers using proteomics is particularly challenging because specific biomarkers are expected to be low abundance proteins with normal blood concentrations of low nanograms per milliliter or less. Conventional, one- and two-dimensional proteomic methods including 2D PAGE, 2D DIGE, LC-MS/MS, and LC/LC-MS/MS do not have the capacity to consistently detect many proteins in this range. In contrast, new higher dimensional (Hi-D) separation strategies, utilizing more than two dimensions of fractionation, can profile the low abundance proteome. (c) 2006 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据